irinotecan has been researched along with 3-hydroxyflavone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, MC; Day, CH; Ho, TJ; Hsu, HH; Huang, CY; Jeng, LB; Kumar Velmurugan, B; Lin, YM; Padma, VV; Tu, CC | 1 |
| Hui, SC; Kang, C; Lang, HD; Mi, MT; Wang, XL; Yi, L; Zhang, Y; Zhou, M; Zhu, XH | 1 |
2 other study(ies) available for irinotecan and 3-hydroxyflavone
| Article | Year |
|---|---|
Fisetin mediated apoptotic cell death in parental and Oxaliplatin/irinotecan resistant colorectal cancer cells in vitro and in vivo.
Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colonic Neoplasms; Colorectal Neoplasms; Drug Resistance, Neoplasm; Flavonoids; Flavonols; Irinotecan; Male; Mice, Nude; Oxaliplatin; Xenograft Model Antitumor Assays | 2018 |
Synergy between dihydromyricetin intervention and irinotecan chemotherapy delays the progression of colon cancer in mouse models.
Topics: Animals; Chloride Channels; Colonic Neoplasms; Disease Models, Animal; Disease Progression; Drug Synergism; Flavonols; Humans; Irinotecan; Male; Mice; Mice, Inbred C57BL; Mitochondrial Proteins | 2019 |